Globus Medical (GMED) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Globus Medical Reports Third Quarter 2021 Results
November 4, 2021 4:15 PM EDTAUDUBON, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2021.
Worldwide net sales were $229.7Â million, an increase of 6.3% as compared to the third quarter of 2020GAAP net income for the quarter was $47.2Â million, or 20.6% of net sales, which is an increase of 6.8% as compared to the third quarter of 2020GAAP diluted earnings per share (EPS) was $0.45 and non-GAAP diluted EPS was... More